Caroline Zöllner

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Katja Deterding, Christoph D. Spinner, Eckart Schott et al. · The Lancet Infectious Diseases · 2016 · 129 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

Christopher Dietz-Fricke, Frank Tacke, Caroline Zöllner et al. · JHEP Reports · 2023 · 57 citations · Full text

Real‐life experiences with bulevirtide for the treatment of hepatitis delta—48 weeks data from a German centre

Caroline Zöllner, Jörg Hofmann, K. Lutz et al. · Liver International · 2022 · 25 citations · Full text

Insecticide-treated mosquito nets in rural Burkina Faso: assessment of coverage and equity in the wake of a universal distribution campaign

Caroline Zöllner, Manuela De Allegri, Valérie R. Louis et al. · Health Policy and Planning · 2014 · 21 citations · Full text

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis

Elisabetta Degasperi, Maria Paola Anolli, Mathias Jachs et al. · Journal of Hepatology · 2025 · 18 citations